K279-1235 Screening compound: 2-({3-[2-(BUTYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-CYCLOHEXYLBUTANAMIDE

K279-1235 Screening compound: 2-({3-[2-(BUTYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-CYCLOHEXYLBUTANAMIDE
K279-1235 Screening compound: 2-({3-[2-(BUTYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-CYCLOHEXYLBUTANAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound K279-1235
2-({3-[2-(BUTYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-CYCLOHEXYLBUTANAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K279-1235

Molecular Formula

C26H35N5O3S (C26 H35 N5 O3 S)

Compound Name

2-({3-[2-(BUTYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-CYCLOHEXYLBUTANAMIDE

IUPAC name

n/a

SMILES

CCCCNC(CC1N2C(SC(CC)C(NC3CCCCC3)=O)=Nc(cccc3)c3C2=NC1=O)=O

InChI

InChI=1S/C26H35N5O3S/c1-3-5-15-27-22(32)16-20-24(33)30-23-18-13-9-10-14-19(18)29-26(31(20)23)35-21(4-2)25(34)28-17-11-7-6-8-12-17/h9-10,13-14,17,20-21H,3-8,11-12,15-16H2,1-2H3,(H,27,32)(H,28,34)

InChI Key

BIFFHBJSLWSQIR-UHFFFAOYSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

497.66

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.483

Distribution Coefficient, logD

3.480

Water Solubility, LogSw

-3.91

Polar Surface Area

84.146

Acid Dissociation Constant (pKa)

11.05

Base Dissociation Constant (pKb)

5.16

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

57.70

K279-1235 in Drug Discovery

Included in Screening Libraries

Eccentric PPI Library (11937 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with K279-1235 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K279-1235?
Check Price and Availability of K279-1235, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K279-1235 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K279-1235
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K279-1235
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K279-1235 available by request